Search results:
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Haloprogin (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | N.R. | Not registered or not marketed. |
| Isoconazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | OTC | Isoconazole nitrate. External use but in the case of vaginal use, only external use for the treatment of vaginal candidiasis. Pharmacy only status. |
| Ketoconazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1995 | UK | OTC | Pharmacy only supply as shampoo for the prevention and treatment of dandruff and seborrhoeic dermatitis of the scalp. Maximum frequency of application: once every 3 days, maximum strength: 2% w/v, maximum pack size: 120ml of product, containing not more than 2400mg of ketoconazole. Pharmacy only supply also for the treatment of tinea pedis, tinea cruris and candidal intertrigo. Maximum strength: 2% w/w. General Sale (GSL) (in 2002) supply where a shampoo, for the prevention and treatment of dandruff and where maximum strength 2% w/v, maximum pack size 100ml of product. GSL also as a cream, for the treatment of tinea pedis and tinea cruris, with maximum strength 2% w/w and maximum pack size 30g. |
| Miconazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1997 | UK | OTC | Miconazole nitrate. Maximum strength 2% for cream or powder (in case of spray powders 2% w/w excluding any propellants). General Sale for external use for the treatment of tinea pedis only. Pharmacy only status for fungal and associated bacterial infections of skin including nappy rash. |
| Miconazole & Hydrocortisone (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | OTC | Pharmacy only for the treatment of athlete's foot and candidal intertrigo. Maximum strength hydrocortisone 1%, maximum pack/container size 15g. |
| Naftifine (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | Rx | — |
| Natamycin (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | Rx | — |
| Neticonazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | N.R. | Not registered or not marketed. |
| Nystatin | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1999 | UK | OTC | Pharmacy only when for external use in combination with Hydrocortisone of maximum strength 0.5 per cent for intertrigo. For use in adults and children not less than 10 years. Maximum strength 3%, maximum pack size 15g. |
| Oxiconazole | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | N.R. | Not registered or not marketed. |
| Selenium sulphide | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | OTC | Pharmacy only status. Shampoo for the management of simple dandruff and seborrhoeic dermatitis of the scalp in adults and children over 5 years. |
| Sulconazole nitrate (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | OTC | Pharmacy only status. External use (except vaginal use). However there is currently no marketed OTC product. |
| Terbinafine | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 2000 | UK | OTC | In 2001, the 1% spray formulation was allowed for sale without a prescription for the treatment of tinea pedis, tinea cruris, and tinea corporis. Maximum strength 1%, maximum pack size 30ml. In 2001, the 1% gel formulation was allowed for the same indications in a maximum pack size of 30g. As from 2004, a cream preparation may be supplied as a General Sale medicine for the treatment of tinea pedis and tinea cruris (max pack size 15g). As from November 2009, a 1% cutaneous solution, to be administered as a single application (max pack size 4g), may be supplied on general sale for the treatment of tinea pedis in persons aged 18 years and older. |
| Tioconazole | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1994 | UK | OTC | Pharmacy only for external use, maximum strength 2%. Pharmacy supply when for the treatment of vaginal candidiasis. However there is currently no marketed OTC product. |
| Tolnaftate | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | — | UK | OTC | General Sale when for external use only. |
| Hyaluronic acid (topical) | D Dermatologicals. Dermatologicals | D03. Preparations for treatment of wounds and ulcers | — | UK | N.R. | Not registered or not marketed. |
| Calcipotriol | D Dermatologicals. Dermatologicals | D05. Antipsoriatics | 2017 | UK | OTC | Calcipotriol 50 microgram/g ointment for the topical treatment of mild to moderate plaque psoriasis which has been previously diagnosed by a doctor in adults aged 18 years of age and over. Application once daily, maximum weekly dose 60g, maximum duration of use 12 weeks, pack size 60g ointment. Pharmacy-only. |
| Aciclovir (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | 1993 | UK | OTC | Maximum strength 5%. For treatment of herpes simplex virus infections of the lips and face (herpes labialis). Maximum pack/container size 2g. From 2004, 5% cream may be supplied on general sale for the treatment of cold sores. |
| Chlortetracycline (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Docosanol (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | OTC | Switched from pharmacy-only to General sale status in 2017. For external use only, for the treatment of early stages (prodrome or erythema phase) of recurrent labial herpes simplex infection (cold sores) in immunocompetent patients aged 12 years and over. Maximum strength 10%, maximum pack size 2g. |
| Famciclovir | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Idoxuridine (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Lysozyme HCl | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | N.R. | Not registered or not marketed. |
| Mupirocin (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Penciclovir (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | 2006 | UK | OTC | In 2014 switched from Pharmacy only to General sale status. For external use for the treatment of herpes simplex virus infections of the lips and face (herpes labialis) in adults and children aged 12 years or over. Maximum strength 1%, maximum pack size 2g. |
| Podofilox (Podophyllotoxin) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Silver sulphadiazine 1% | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Tetracycline | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | UK | Rx | — |
| Alclometasone (topical) | D Dermatologicals. Dermatologicals | D07. Corticosteroids, dermatological preparations | 2009 | UK | OTC | Alclometasone dipropionate 0.05% w/w cream is available from pharmacies only for the short-term treatment and control of patches of eczema and dermatitis including atopic eczema and primary irritant and allergic dermatitis in adults and children aged 12 years and older. Maximum pack size 15g. |
| Clobetasone butyrate (topical) | D Dermatologicals. Dermatologicals | D07. Corticosteroids, dermatological preparations | 2001 | UK | OTC | Pharmacy only status. For the short-term symptomatic treatment and control of patches of eczema and dermatitis (excluding seborrhoeic dermatitis) in adults and in children aged 12 years and over. Maximum strength 0.05%, maximum pack size 15g. |
| Hydrocortisone (topical) | D Dermatologicals. Dermatologicals | D07. Corticosteroids, dermatological preparations | 1987 | UK | OTC | Pharmacy status: Maximum strength 1%. For use as a cream, ointment or spray either alone or in conjunction with crotamiton in irritant dermatitis, contact allergic dermatitis, insect bite reactions, mild to moderate eczema, and either in combination with clotrimazole or miconazole nitrate for athlete's foot and candidal intertrigo or in combination with lidocaine for anal and perianal itch associated with haemorrhoids. For use in adults and children 10 years or over. Maximum strength 0.5% for use in combination with nystatin of maximum strength 3% for intertrigo. Also see CSM Guidelines. Container or package containing not more than 15g of medicinal product (cream or ointment) or 30ml (spray). May be supplied on General sale: A spray containing hydrocortisone 0.2% and lidocaine hydrochloride 1.0% for the symptomatic relief of anal and perianal itch, irritation and pain associated with external haemorrhoids, maximum pack size 30ml. A cream for the treatment of insect bite and sting reactions, only, for use in adults and children aged 10 years and over, maximum strength 1%, maximum pack size 15g (switched in 2007 to GSL). |
| Prednisolone | D Dermatologicals. Dermatologicals | D07. Corticosteroids, dermatological preparations | — | UK | Rx | — |
| Triamcinolone | D Dermatologicals. Dermatologicals | D07. Corticosteroids, dermatological preparations | — | UK | OTC | ATC code R01: Triamcinolone acetonide non-pressurised nasal spray switched to pharmacy-only status in 2000 to treat symptoms of seasonal allergic rhinitis in those aged 18 years and over, for no longer than three months in containers of not more than 3.575mg labelled with a maximum dose and maximum daily dose of 110 micrograms per nostril. ATC code A01: Triamcinolone acetonide available as a pharmacy-only medicine with a maximum strength of 0.1% in packages containing not more 5g of medicinal product, for the treatment of common mouth ulcers. Maximum treatment period 5 days. Product discontinued March 2009. |
| Benzalkonium chloride | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | UK | OTC | Whether external or internal (e.g. pastilles, lozenges, throat tablets), maximum strength for general sale is 600 micrograms. |
| Povidone iodine | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | UK | OTC | All preparations may be supplied on gerneal sale except those for use in surgical operations and those for vaginal use. |
| Triclosan | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | UK | OTC | General sale supply if for external use only. |
| Benzoyl peroxide | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | 1997 | UK | OTC | General Sale if maximum strength 2.5% for the treatment of spots or pimples on the face. Pharmacy only for external use with maximum strength 10%. |
| Clindamycin | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | UK | Rx | — |
| Erythromycin (topical) | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | UK | Rx | — |
| Tretinoin | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | UK | Rx | — |
| Minoxidil (topical) | D Dermatologicals. Dermatologicals | D11. Other dermatological preparations | 1994 | UK | OTC | Pharmacy-only status: Maximum strength 5% for the treatment of alopecia androgenetica in men and women aged 18-65 years (5% foam for use in women switched from prescription-only to Pharmacy-only status in November 2015). Maximum pack size for men: 3 x 73ml. Maximum pack size for women: 2 x 73ml (equivament to 2 x 60g product providing 120 days' supply). Switched from Pharmacy only to General sale in 2002: Solution, gel or foam for the treatment of alopecia androgenetica in men aged between 18 and 65 years, maximum strength 5%, maximum pack size 3g of minoxidil. |
| Butoconazole | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | — | UK | N.R. | Not registered or not marketed. |
| Clotrimazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | 1992 | UK | OTC | External use for treatment of vaginal candidiasis. Pharmacy only status. As from 2004, a combination pack of a 500mg pessary (for the treatment of vaginal candidiasis) and 2% (maximum 200mg of clotrimazole per pack) cream (for the treatment of candidal vulvitis and as an adjunct to treatment of candidal vaginitis) may be supplied on general sale. |
| Miconazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | 1992 | UK | OTC | External use only for the treatment of vaginal candidiasis. Pharmacy only status. |
| Propionate Ca+Na (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | — | UK | N.R. | Not registered or not marketed. |
| Estriol (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G03. Sex hormones and modulators of the genital system | — | UK | Rx | — |
| Levonorgestrel | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G03. Sex hormones and modulators of the genital system | 2001 | UK | OTC | Pharmacy only supply since 2001 as an emergency hormonal contraceptive for women aged 16 years and over. Otherwise it can be prescribed for any age group. Maximum strength 1.5mg. |
| Flavoxate hydrochloride | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | UK | Rx | — |
| Phenazopyridine | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | UK | N.R. | Not registered or not marketed. |
| Tamsulosin | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | 2009 | UK | OTC | The United Kingdom became the first country in the world in December 2009 to switch the ingredient tamsulosin to non-prescription (pharmacy-only) status for the short-term (6 weeks) treatment of functional symptoms of benign prostatic hyperplasia (BPH) in men aged 45 to 75 years following a consultation with a pharmacist. Maximum strength 400 micrograms, maximum daily dose 400 micrograms, maximum pack size 28 capsules. Patients will need to obtain a GP diagnosis prior to longer-term use and annual check-ups are recommended thereafter. Tamsulosin will also continue to be available on prescription. |